Copy number variation in CCL3L1 gene is associated with susceptibility to acute rejection in patients after liver transplantation

Clinical Transplantation

Volumn 26, Issue 2, 2012, Pages 314-321

  Li, Hong ^a   Xie, Hai Yang ^a   Zhou, Lin ^a   Feng, Xiao Wen ^a   Wang, Wei Lin ^a   Liang, Ting Bo ^a   Zhang, Min ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute rejection; CCL3L1; Chemokine receptor 5; Copy number variation; Liver transplantation

Indexed keywords

GENOMIC DNA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHINESE; COPY NUMBER VARIATION; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ACUTE DISEASE; CHEMOKINE CCL3; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84859842326     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01486.x     Document Type: Article

References (28)

1. Shaked A, Ghobrial RM, Merion RM et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant 2009: 9: 301.
2. Hancock WW, Wang L, Ye Q, Han R, Lee I. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003: 15: 479.
3. Abdi R, Smith RN, Makhlouf L et al. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 2002: 51: 2489.
4. Bickerstaff A, Nozaki T, Wang JJ et al. Acute humoral rejection of renal allografts in CCR5(-/-) recipients. Am J Transplant 2008: 8: 557.
5. Dehmel S, Wang S, Schmidt C et al. Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome. Eur J Immunol 2010: 40: 267.
6. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. J Leukoc Biol 1996: 60: 147.
7. Modi WS. CCL3L1 and CCL4L1 chemokine genes are located in a segmental duplication at chromosome 17q12. Genomics 2004: 83: 735.
8. Gonzalez E, Kulkarni H, Bolivar H et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005: 307: 1434.
9. Townson JR, Barcellos LF, Nibbs RJ. Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol 2002: 32: 3016.
10. Stranger BE, Forrest MS, Dunning M et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007: 315: 848.
11. Willcocks LC, Lyons PA, Clatworthy MR et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008: 205: 1573.
12. McKinney C, Fanciulli M, Merriman ME et al. Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples. Ann Rheum Dis 2010: 69: 1711.
13. Shostakovich-Koretskaya L, Catano G, Chykarenko ZA et al. Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children. AIDS 2009: 23: 679.
14. Colobran R, Casamitjana N, Roman A et al. Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation. Genes Immun 2009: 10: 254.
15. Field SF, Howson JM, Maier LM et al. Experimental aspects of copy number variant assays at CCL3L1. Nat Med 2009: 15: 1115.
16. He W, Kulkarni H, Castiblanco J et al. Reply to: "Experimental aspects of copy number variant assays at CCL3L1." Nat Med 2009: 15: 1117.
17. Demetris A, Adams D, Bellamy C et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 2000: 31: 792.
18. Dell-Olio D, Kelly DA. Immunosuppressants: what's new? Curr Opin Organ Transplant 2010: 15: 594.
19. Duffy JP, Kao K, Ko CY et al. Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg 2010: 252: 652.
20. Shalekoff S, Meddows-Taylor S, Schramm DB et al. Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr 2008: 48: 245.
21. Mamtani M, Rovin B, Brey R et al. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 2008: 67: 1076.
22. McKinney C, Merriman ME, Chapman PT et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008: 67: 409.
23. Grunhage F, Nattermann J, Gressner OA et al. Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. J Hepatol 2010: 52: 153.
24. Hong JC, Kosari K, Benjamin E et al. Does race influence outcomes after primary liver transplantation? A 23-year experience with 2, 700 patients. J Am Coll Surg 2008: 206: 1009.
25. Pilotti E, Elviri L, Vicenzi E et al. Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication. Blood 2007: 109: 1850.
26. Heidenhain C, Puhl G, Moench C, Lautem A, Neuhaus P. Chemokine receptor 5Delta32 mutation reduces the risk of acute rejection in liver transplantation. Ann Transplant 2009: 14: 36.
27. Moench C, Uhrig A, Lohse AW, Otto G. CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation. Liver Transpl 2004: 10: 434.
28. Inoue S, Tahara K, Kaneko T et al. Long-lasting donor passenger leukocytes after hepatic and intestinal transplantation in rats. Transpl Immunol 2004: 12: 123.